MedPath

Adaptive Treatment for Adolescent Cannabis Use Disorders

Not Applicable
Completed
Conditions
Addictive Behaviors
Cannabis Use Disorder
Mental Disorders
Interventions
Behavioral: ACRA
Behavioral: CBT
Registration Number
NCT01656707
Lead Sponsor
UConn Health
Brief Summary

The purpose of this study is to examine an Adaptive Treatment approach in order to improve outcomes of youth with Cannabis Use Disorders who are poor responders to treatment.

Detailed Description

The study will address the current contrasts in youth response to treatment, the problem of poor response to treatment and the prevention of relapse. Results from the study may support Adaptive Treatment as an efficacious approach for youth with Cannabis Use Disorder who are poor responders to treatment.

Poor responders fall into two categories, those who failed to achieve a negative drug urinalysis during the last session of the initial MET/CBT-7 treatment they attended, and those who either dropped out or were administratively discharged at any time during the initial MET/CBT-7 treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
172
Inclusion Criteria
  • 13-18 years of age at the time of intake assessment
  • Current diagnosis of DSM-IV Cannabis Abuse or Dependence
  • Able to read and comprehend English at a 5th grade level
  • Residence within 45 minutes drive from the UCHC Farmington treatment site
  • Participant and a parent/legal guardian responsible for providing collateral information agree to sign an IRB approved consent form
  • Participant and a parent/legal guardian responsible for providing collateral information agree to provide locator information
  • The family is not planning to move from the area during the next six months
Exclusion Criteria
  • Meet criteria for dependence of any other substance of abuse other than nicotine or alcohol
  • Report suicidal ideation with a plan, suicidal behavior, a plan to hurt oneself or other, or a history of self-injurious behavior all occurring in the last 30 days
  • Meet a lifetime diagnosis of schizophrenia
  • Has any current health (i.e. medical, psychiatric) condition that will compromise the participant's ability to regularly attend treatment
  • Demonstrate an inability or unwillingness to provide locator information

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ACRAACRATen weekly 60-minute sessions of Adolescent Community Reinforcement Approach (ACRA) will be provided as an Adaptive treatment condition.
Cognitive Behavioral Therapy (CBT)CBTTen weekly, 60-minute sessions of augmented individualized Cognitive Behavioral Therapy (CBT)will be provided as an Adaptive Treatment condition
Primary Outcome Measures
NameTimeMethod
1.) To evaluate the efficacy of AT for youth who have been defined as poor responders to an evidence-based practice intervention such as the initial MET/CBT-7.one year

Each participant will serve as his/her own control. The outcomes will include the T-ASI, T-ASI-P, and drug urinalyses.

Secondary Outcome Measures
NameTimeMethod
To assess outcomes as a function of mediator variables such as self-efficacy, coping skills, readiness to change, and environmental support (i.e., family and peer), within each of the AT interventions.one year

The secondary outcome measures will include the SCQ, CRI, PRQ, and SSQ.

Trial Locations

Locations (1)

University of Connecticut Health Center

🇺🇸

Farmington, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath